{"transactions":[{"id":2342180,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T23:14:33.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":15528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date."}],"balance_after":15528,"derivative":{"exercise_price":3.8,"expiration_date":"2031-10-03","underlying":"Common Stock","underlying_shares":15528},"source":{"system":"sec-edgar","filing":"0001209191-22-017669","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000120919122017669/doc4a.xml","form_type":"4/A","original_submission_date":"2021-10-06"}},{"id":2547291,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T20:15:18.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":17245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date."}],"balance_after":17245,"derivative":{"exercise_price":3.8,"expiration_date":"2031-10-03","underlying":"Common Stock","underlying_shares":17245},"source":{"system":"sec-edgar","filing":"0000899243-21-039454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924321039454/doc4.xml","form_type":"4"}},{"id":2754533,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-07T20:08:23.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":58855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 5, 2021 with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a Service Relationship with the Company."}],"balance_after":58855,"derivative":{"exercise_price":12.66,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":58855},"source":{"system":"sec-edgar","filing":"0001213900-21-020638","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000121390021020638/ownership.xml","form_type":"4"}},{"id":2789407,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T20:21:56.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 36 equal monthly installments following the Grant Date, provided that as of each such date the Grantee remains in a business relationship with the Company."}],"balance_after":15000,"derivative":{"exercise_price":17,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-015397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000121390021015397/ownership.xml","form_type":"4"}},{"id":3497306,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-07T16:38:51.000Z","date":"2019-06-07","kind":"disposition_to_issuer","acquired":false,"shares":97400,"price":10.76,"value":1048024.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of the Issuer on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the \"Issuer\") may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":14.74,"expiration_date":"2019-01-21","underlying":"Ordinary Shares","underlying_shares":97400},"source":{"system":"sec-edgar","filing":"0001209191-19-035572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119035572/doc4.xml","form_type":"4"}},{"id":3497305,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-07T16:38:51.000Z","date":"2019-06-07","kind":"disposition_to_issuer","acquired":false,"shares":37500,"price":11.26,"value":422250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of the Issuer on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the \"Issuer\") may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":14.24,"expiration_date":"2028-01-30","underlying":"Ordinary Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-19-035572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119035572/doc4.xml","form_type":"4"}},{"id":3497304,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-07T16:38:51.000Z","date":"2019-06-07","kind":"disposition_to_issuer","acquired":false,"shares":80479,"price":25.5,"value":2052214.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the \"Issuer\") may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-035572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119035572/doc4.xml","form_type":"4"}},{"id":3565081,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T21:01:07.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":2446,"price":25.31,"value":61908.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected by the Reporting Person to cover tax liabilities pursuant to the Issuer's mandatory sell-to-cover policy."}],"balance_after":80479,"source":{"system":"sec-edgar","filing":"0001209191-19-023560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119023560/doc4.xml","form_type":"4"}},{"id":3688077,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T21:03:02.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":97400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 1, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":97400,"derivative":{"exercise_price":14.74,"expiration_date":"2029-01-21","underlying":"Ordinary Shares","underlying_shares":97400},"source":{"system":"sec-edgar","filing":"0001209191-19-005264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119005264/doc4.xml","form_type":"4"}},{"id":3699096,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-09T21:12:58.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":2546,"price":12.9808,"value":33049.1168,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected by the Reporting Person to cover tax liabilities pursuant to the Issuer's mandatory sell-to-cover policy."}],"balance_after":82925,"source":{"system":"sec-edgar","filing":"0001209191-19-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119003181/doc4.xml","form_type":"4"}},{"id":3699097,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-09T21:09:24.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":4070,"price":12,"value":48840.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4 has been amended to include all unvested restricted shares disclosed in the Reporting Person's Form 3 in Column 5 of this Form 4/A. This Form 4/A amends and restates, in its entirety, the original Form 4."}],"balance_after":85471,"source":{"system":"sec-edgar","filing":"0001209191-19-003178","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119003178/doc4a.xml","form_type":"4/A","original_submission_date":"2019-01-07"}},{"id":3702014,"issuer":{"id":156809,"kind":"organization","name":"Nightstar Therapeutics plc","symbol":"NITE"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-07T21:20:27.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":4070,"price":12,"value":48840.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":4070,"source":{"system":"sec-edgar","filing":"0001209191-19-002676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1673178/000120919119002676/doc4.xml","form_type":"4"}},{"id":4499403,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-01-06T00:13:24.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018."}],"balance_after":35000,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001070081-17-000025","document":"wf-form4_148366159127249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000025/wf-form4_148366159127249.xml","form_type":"4"}},{"id":4499402,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":129328,"kind":"person","name":"Ong Tuyen","position":1,"cik":"0001673178","reported_name":"Ong Tuyen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-06T00:13:24.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001070081-17-000025","document":"wf-form4_148366159127249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000025/wf-form4_148366159127249.xml","form_type":"4"}}]}